Zoya Brar Resigned, Steps Down from the Board of CORE Diagnostics

India: After eight years as CEO, Zoya Brar, is resigning from the Board of CORE Diagnostics and leave office by August 31, the company said today. The company statement said that Brar is moving on but she will continue to support the company as an advisor to the board and the CEO. “I am going to take some personal time before letting my love for entrepreneurship take over my life again,” Brar said.

Brar founded CORE Diagnostics in 2012. It is a high-end clinical laboratory that provides next-generation diagnostics for preventive healthcare, precise disease stratification and therapy selection. Headquartered in the National Capital Region, CORE has a sprawling 20,000 Sq.ft lab space which is accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL).

Dinesh Chauhan, the current COO, will be the new CEO starting September 1, 2020. He will also join the board of directors of the company. Dinesh is a founding member of the company and joined CORE in 2013. He has over 30+ years of experience in the diagnostics industry. “Taking over from a Founder-CEO is never easy but I am looking forward to all the opportunities and challenges this next phase will bring,” Chauhan said.

CORE Diagnostics is backed by Artiman Ventures, F-Prime, and Eight Roads. Dr Ajit Singh, the Executive Chairman of the board said, “When Zoya founded this company in 2012, everything about it was nascent, true to the literal meaning of the word – the entrepreneur, the business idea, and the readiness of the market. In the years that followed, CORE has become synonymous with innovative molecular diagnostics and a clear market leader in the field. On behalf of the board of directors of the company, I want to congratulate Zoya and her team for these remarkable achievements, and wish Dinesh the very best.”